REG - Craneware plc - Grant of Long Term Incentive Plan Awards

CranewareAnnouncement

21/11/2022 11:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221121:nRSU0860Ha&default-theme=true

RNS Number : 0860H  Craneware plc  21 November 2022

 

Craneware plc

("Craneware" or the "Company")

 

Grant of Long Term Incentive Plan Awards

 

21 November 2022 - The Board of Craneware plc (AIM: CRW.L), the market leader
in Value Cycle software solutions for the US healthcare market, announces that
on 18 November 2022, under the terms of the Craneware plc Long Term Incentive
Plan (2022) ("LTIP"), a conditional award of ordinary shares of 1p each in the
Company ("Shares") was granted to three Directors of the Company as follows:
 

 

 Director               No. of Shares over which a conditional share award was granted  Percentage of issued share capital
 Keith Neilson (CEO)    30,796                                                          0.09%
 Craig Preston (CFO)    22,890                                                          0.06%
 Isabel Urquhart (CPO)  15,734                                                          0.04%

 

The awards will ordinarily vest after three years subject to:

 

(i) the satisfaction of certain performance conditions (each with 50%
weighting) based on: (a) the Company's total shareholder return ("TSR")
performance relative to the performance achieved by the constituent companies
within the FTSE AIM 100 Index; and (b) compound annual growth in adjusted
diluted earnings per share, as reported in the consolidated financial
statements of the Company and its subsidiaries; and

(ii) the Director's continued employment.

 

The performance conditions are measured in three tranches such that one third
of the Shares over which the LTIP awards subsist will vest based on
performance over the three years ending on 30 June 2023, one third based on
performance over the three years ending 30 June 2024 and the final third based
on performance over the three years to 30 June 2025 - an aggregate five year
period. Any tranche (or part thereof) that does not meet the performance
criteria will lapse.

 

If and to the extent that these LTIP awards vest, the resulting (net of tax)
Shares will be subject to a two year holding period.

 

There was no consideration for the grant of the LTIP awards and no
consideration will be payable by the award holders to receive the Shares from
these LTIP awards, if and to the extent that they vest.

 

PDMR notification: Keith Neilson

 

1.   Details of the Restricted Person / person closely associated with him
or her

a) Name
                        Keith Neilson

 

2.   Reason for the notification

a) Position /
status
CEO

b) Initial notification / Amendment                     Initial
notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
            Craneware plc

b)
LEI
                        213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code
ISIN GB00B2425G68

 

c) Nature of the transaction
Grant of conditional share award under the Craneware plc

 
                       Long Term Incentive Plan (2022)

 

d) Price(s) and
volume(s)
Volume(s) granted 30,796, Price(s) £0

 

e) Aggregated information:

                                    i. Aggregated volume
    Aggregate volume granted 30,796

                                    ii.
Price
Price(s) £0

 

f) Date of the transaction
           2022-11-18

 

g) Place of the
transaction
Outside a trading venue

 

PDMR notification: Craig Preston

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Craig Preston

 

2.   Reason for the notification

a) Position / status
                                    CFO

b) Initial notification / Amendment                     Initial
notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code
ISIN GB00B2425G68

 

c) Nature of the
transaction
Grant of conditional share award under the Craneware plc

 
                        Long Term Incentive Plan (2022)

 

d) Price(s) and
volume(s)
Volume(s) granted 22,890, Price(s) £0

 

e) Aggregated information:

                                    i. Aggregated volume
    Aggregate volume granted 22,890

                                    ii. Price
                  Price(s) £0

 

f) Date of the transaction
 2022-11-18

 

g) Place of the
transaction
Outside a trading venue

 

PDMR notification: Isabel Urquhart

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Isabel Urquhart

 

2.   Reason for the notification

a) Position /
status
Chief People Officer

b) Initial notification /
Amendment                       Initial notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code
ISIN GB00B2425G68

 

c) Nature of the
transaction
Grant of conditional share award under the Craneware plc

 
                        Long Term Incentive Plan (2022)

 

d) Price(s) and
volume(s)
Volume(s) granted 15,734, Price(s) £0

 

e) Aggregated information:

                                    i.
Aggregated volume                Aggregate volume granted
15,734

                                    ii.
Price
Price(s) £0

 

f) Date of the transaction
           2022-11-18

 

g) Place of the
transaction
Outside a trading venue

 

 

 

 

 

 

For further information, please contact:

 

 Craneware plc                                               +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma (Financial PR)                                         +44 (0)20 3405 0205
 Caroline Forde, Hilary Buchanan, Joe Pederzolli             craneware@almapr.co.uk

 Peel Hunt (NOMAD and Joint Broker)                          +44 (0)20 7418 8900
 Dan Webster, Andrew Clark

 Investec Bank PLC (Joint Broker)                            +44 (0)20 7597 5970
 Patrick Robb, Henry Reast, Sebastian Lawrence
 ( )                                                         ( )
 Berenberg (Joint Broker)                                    +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

 

About Craneware

 

We at The Craneware Group of companies, including our latest additions Sentry
Data Systems and Agilum Healthcare Intelligence, passionately believe we can
impact healthcare profoundly by delivering the insights healthcare
organisations need to also transform the business of healthcare. Our shared
vision is to be the operational and financial partner for US healthcare
providers.

 

Our combined suite of applications and industry-leading team of experts help
our customers contextualise operational, financial, and clinical data,
providing insights that clearly demonstrate what great looks like. These value
cycle insights deliver revenue integrity and 340B compliance, as well as
margin and operational intelligence- something no other single partner can
provide.

 

Together, approximately 40% of registered US hospitals are now our customers,
including more than 12,000 US hospitals, health systems and affiliated retail
pharmacies and clinics. Our customers are operating with a financial impact of
nearly half a trillion dollars. We have data sets from customers covering more
than 150 million unique patients encounters.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFEIFFFEESEDF